Nu Skin Enterprises, Inc.
NUS- Exchange
- NYSE
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries
- SEC CIK
- 0001021561
No open-market purchases or sales by Nu Skin Enterprises, Inc. insiders were filed in the last 90 days; 162 institutions reported holding it in 13F filings for Q2 2026, worth $191.1M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Nu Skin Enterprises, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Nu Skin Enterprises, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Woodbury Edwina D | Director | 62,474 | Sep 10, 2026 | 5 |
| Campbell Daniel W | Director | 65,859 | Jun 3, 2026 | 1 |
| Zorko Mark A | Director | 60,586 | Jun 3, 2026 | 1 |
| Thomas Pisano R. | Director | 116,827 | Jun 3, 2026 | 1 |
| Battle Emma S. | Director | 57,648 | Jun 3, 2026 | 1 |
| Nathanson Laura | Director | 57,116 | Jun 3, 2026 | 2 |
| Winett James M | Director | 37,448 | Jun 3, 2026 | 1 |
| Napierski Ryan S | President and CEO | 1,001,905 | Mar 9, 2026 | 4 |
| Thomas James D | Chief Financial Officer | 267,102 | Mar 9, 2026 | 4 |
| Clark Chayce David | EVP, COO and CLO | 390,746 | Mar 9, 2026 | 5 |
| Hatchett Steven Keith | Chief Product Officer | 260,818 | Mar 9, 2026 | 5 |
| Keisel Justin S | EVP, President of Global Sales | 160,170 | Mar 9, 2026 | 4 |
| Shen Zheqing | Director | 33,195 | Jun 10, 2024 | 0 |
| Lipman Andrew D | Director | 23,225 | May 28, 2024 | 0 |
| Tang Connie Mang Yee | Chief Global Growth Officer | 43,204 | Apr 25, 2023 | 0 |
| Lund Steven | Exec. Chairman of the Board | 113,574Indirect | Mar 3, 2023 | 0 |
| Chang Joseph Y | Chief Scientific Officer | 21,234 | Mar 3, 2023 | 0 |
| Lawrence Mark H | Chief Financial Officer | 57,146 | Mar 3, 2023 | 0 |
| Bettinger Jeffrey Clark | SVP, People and Places Officer | 16,068 | Oct 5, 2021 | 0 |
| Dorny D Matthew | General Counsel | 47,159 | Jul 6, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2022 (view filing) | Jun 23 | Same day | Lund StevenExec. Chairman of the Board | SSaleClass A Common Stock | −17.1K | $45.18 | −$773.8K | −45.2%20.8K after | 2 lots |
| Jun 22, 2022 (view filing) | Jun 22 | Same day | Lipman Andrew DDirector | SSaleClass A Common Stock | −1.00K | $44.06 | −$44.1K | −1.4%72.4K after | |
| Jun 22, 2022 (view filing) | Jun 17-22 | 5 days | Lund StevenExec. Chairman of the Board | SSaleClass A Common Stock | −8.13K | $45.02 | −$365.8K | −26.1%23.0K after | 6 lots |
| Jun 15, 2022 (view filing) | Jun 13-15 | 2 days | Lund StevenExec. Chairman of the Board | SSaleClass A Common Stock | −51.7K | $43.84 | −$2.27M | −65.7%27.0K after | 6 lots |
| Jun 8, 2022 (view filing) | Jun 6 | 2 days | Lawrence Mark HChief Financial Officer | SSaleClass A Common Stock | −5.87K | $47.03 | −$276.0K | −10.8%48.2K after | |
| Jun 2, 2022 (view filing) | Jun 1 | 1 day | Chang Joseph YChief Scientific Officer | SSaleClass A Common Stock | −16.0K | $46.57 | −$745.1K | −41.1%23.0K after | 2 lots |
| May 26, 2022 (view filing) | May 25 | 1 day | Napierski Ryan SPresident and CEO | SSaleClass A Common Stock | −25.0K | $44.91 | −$1.12M | −16.9%122.7K after | 2 lots |
| May 23, 2022 (view filing) | May 23 | Same day | Lipman Andrew DDirector | SSaleClass A Common Stock | −1.00K | $44.95 | −$45.0K | −1.4%70.2K after | |
| May 18, 2022 (view filing) | May 16-18 | 2 days | Lund StevenExec. Chairman of the Board | SSaleClass A Common Stock | −22.1K | $45.28 | −$1.00M | −11.0%179.4K after | From original2 lots |
| Apr 22, 2022 (view filing) | Apr 22 | Same day | Lipman Andrew DDirector | SSaleClass A Common Stock | −1.00K | $47.72 | −$47.7K | −1.4%71.2K after | |
| Mar 23, 2022 (view filing) | Mar 22 | 1 day | Lipman Andrew DDirector | SSaleClass A Common Stock | −1.00K | $47.40 | −$47.4K | −1.4%72.2K after | |
| Mar 3, 2022 (view filing) | Mar 2 | 1 day | Chang Joseph YChief Scientific Officer | SSaleClass A Common Stock | −3.42K | $46.04 | −$157.6K | −13.0%23.0K after | 2 lots |
| Mar 1, 2022 (view filing) | Mar 1 | Same day | Chang Joseph YChief Scientific Officer | SSaleClass A Common Stock | −28.6K | $45.22 | −$1.29M | −55.5%23.0K after | 2 lots |
| Mar 1, 2022 (view filing) | Feb 25 | 4 days | Napierski Ryan SPresident and CEO | SSaleClass A Common Stock | −25.0K | $47.40 | −$1.19M | −16.9%122.7K after | 2 lots |
| Feb 23, 2022 (view filing) | Feb 22 | 1 day | Lipman Andrew DDirector | SSaleClass A Common Stock | −1.00K | $53.27 | −$53.3K | −1.3%73.2K after | |
| Jan 24, 2022 (view filing) | Jan 24 | Same day | Lipman Andrew DDirector | SSaleClass A Common Stock | −1.00K | $50.50 | −$50.5K | −1.3%74.2K after | |
| Oct 5, 2021 (view filing) | Oct 5 | Same day | Bettinger Jeffrey ClarkSVP, People and Places Officer | SSaleClass A Common Stock | −1.63K | $41.10 | −$66.8K | −9.2%16.1K after | |
| Sep 13, 2021 (view filing) | Sep 13 | Same day | Chang Joseph YEVP, Chief Scientific Officer | SSaleClass A Common Stock | −16.0K | $47.41 | −$758.6K | −47.1%17.9K after | |
| Jul 6, 2021 (view filing) | Jul 2 | 4 days | Dorny D MatthewGeneral Counsel | SSaleClass A Common Stock | −6.20K | $56.88 | −$352.7K | −11.6%47.2K after | 2 lots |